We will rely on you to help lend your voice and support the biotechnology industry.
Learn more about BIO initiatives to advance the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO CEO & Investor Conference
February 12-13, 2018
BIO IP Counsels Committee Conference
April 11-13, 2018
BIO Industry Analysis Reports
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
July 16 - 19, 2018 | Philadelphia, Pennsylvania
David Sudolsky, CEO, Anellotech
Anellotech’s patented Bio-TCat™ process produces BTX aromatics (a mix of benzene, toluene and xylene isomers) which are chemically identical to petro-based counterparts. Bio-based BTX aromatics can be used to make commodity plastics such as polyester (polyethylene terephthalate or PET), polystyrenes, polycarbonates, nylons and polyurethanes. These are used to manufacture consumer goods such as beverage bottles, food packaging, clothing, footwear, carpeting, automotive and electronic components. Currently using loblolly pine, Bio-TCat™ can process other readily available non-food inputs, which are a renewable and cheaper feedstock than sugar. Investments have been secured from industry-leading companies in the BTX supply chain, including Suntory and Toyota Tsusho. These investments help fund Anellotech’s further development of the Bio-TCat™ technology as the company works towards commercial-scale plant designs.
Lisa Kennedy, Director, Business Development, Genomatica
Performance, economics and value chains driving renewables: three examples: What does it take to see substantial use of renewables in everyday consumer products? This presentation will share Genomatica’s experiences in advancing three major programs and products into multiple markets. We’ll discuss the varied roles that performance, economics and the establishment of product value chain support have held for our commercial GENO BDO program; our Brontide BG; and for our nylon-6 program under development.
Richard Pieters, President, Products, Zymergen
The Unique Opportunity to Create Specialty Products and Materials based on Biotechnology: Innovative new materials are needed to fulfill the most demanding performance requirements in industries from electronics, to biomedical, personal care and more. Yet over the past century, the pace of material innovation from traditional material and product innovators has slowed. The economics of developing very complex molecules to fulfill specialty needs are difficult to justify. However, Industrial Biotechnology offers significant opportunities to kick-start the development and launch of novel materials that are not economically feasible otherwise. Zymergen's platform unlocks new chemical building blocks to enable novel material and product development. This talk will discuss the company's platform and our work to launch new specialty products for the electronics, personal care and other industries.